Newsroom | Page 31 of 31 | Merck Animal Health USA

Newsroom

January 31, 2014

Harrisvaccines Awarded Rotavirus C Autogenous Licensure

AMES, Iowa, January 30, 2014 – Ames, Iowa-based vaccine producer, Harrisvaccines, today announced it has been granted United States Department of Agriculture (USDA) autogenous licensure of the company’s Rotavirus C vaccine utilizing its SirraVaxSM RNA Particle Technology, approved by the Department’s Center for Veterinary Biologics (CVB) for disease caused by Rotavirus subtype C. Rotavirus C […]

January 21, 2014

Merck Animal Health Launches new addition to the Circumvent G2 Product Line Ready-To-Use PCV2 and M. hyo Vaccine

DE SOTO, Kan., – Jan. 21, 2014 – Merck Animal Health today introduced Circumvent® PCV-M G2 – a porcine circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae combination vaccine. The new vaccine is the only one-dose or two-dose, ready-to-use combination with five-month PCV2 duration of immunity, which is 25 percent longer than any other PCV2 vaccine on […]